Bone is the principal site of metastasis for many carcinomas, including prostate. Once bone
metastases are established, the chances of survival dramatically drop. Bone metastases place patients at
increased risk of skeletal-related events, including pathologic fractures, bone pain and hypercalcemia.
Indeed, skeletal metastases represent the prevalent cause of morbidity and mortality for many tumors.
They are the result of interactions among tumour cells, bone marrow environment and bone cells (vicious
cycle). In the last few years many efforts were undertaken to identify new therapeutic approaches
for bone metastasis. Current therapies target the several players of bone vicious cycle. However many adverse
effects are associated with these treatments. This review will focus on the new emerging sector of nanomedicine, that
could be important to identify more specific and safe treatments for bone metastasis.